Engineered Gut Bacteria Therapy Emerges as Scalable Potential Alternative to Fecal Microbiota Transplants Following Clinical Trial
June 02, 2026
June 02, 2026
NEW YORK, June 2 [Category: BizHospital] -- Mount Sinai Health System posted the following news release:
* * *
Engineered Gut Bacteria Therapy Emerges as Scalable Potential Alternative to Fecal Microbiota Transplants Following Clinical Trial
*
Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform for producing targeted mixtures of beneficial gut bacteria, an approach that could help expand access . . .
* * *
Engineered Gut Bacteria Therapy Emerges as Scalable Potential Alternative to Fecal Microbiota Transplants Following Clinical Trial
*
Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform for producing targeted mixtures of beneficial gut bacteria, an approach that could help expand access . . .